JPWO2022264109A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022264109A5 JPWO2022264109A5 JP2023577590A JP2023577590A JPWO2022264109A5 JP WO2022264109 A5 JPWO2022264109 A5 JP WO2022264109A5 JP 2023577590 A JP2023577590 A JP 2023577590A JP 2023577590 A JP2023577590 A JP 2023577590A JP WO2022264109 A5 JPWO2022264109 A5 JP WO2022264109A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- vaccine composition
- antigen
- influenza vaccine
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163212523P | 2021-06-18 | 2021-06-18 | |
| US63/212,523 | 2021-06-18 | ||
| EP21315198 | 2021-10-13 | ||
| EP21315198.8 | 2021-10-13 | ||
| US202163276243P | 2021-11-05 | 2021-11-05 | |
| PCT/US2021/058250 WO2022099003A1 (en) | 2020-11-06 | 2021-11-05 | Lipid nanoparticles for delivering mrna vaccines |
| US63/276,243 | 2021-11-05 | ||
| USPCT/US2021/058250 | 2021-11-05 | ||
| PCT/IB2022/055655 WO2022264109A1 (en) | 2021-06-18 | 2022-06-17 | Multivalent influenza vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024528418A JP2024528418A (ja) | 2024-07-30 |
| JPWO2022264109A5 true JPWO2022264109A5 (https=) | 2025-06-24 |
| JP2024528418A5 JP2024528418A5 (https=) | 2025-06-24 |
Family
ID=82258335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577590A Pending JP2024528418A (ja) | 2021-06-18 | 2022-06-17 | 多価インフルエンザワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230043128A1 (https=) |
| EP (1) | EP4355308A1 (https=) |
| JP (1) | JP2024528418A (https=) |
| KR (1) | KR20240022610A (https=) |
| AU (1) | AU2022294274A1 (https=) |
| CA (1) | CA3224175A1 (https=) |
| IL (1) | IL309408A (https=) |
| MX (1) | MX2023015464A (https=) |
| WO (1) | WO2022264109A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022099003A1 (en) | 2020-11-06 | 2022-05-12 | Sanofi | Lipid nanoparticles for delivering mrna vaccines |
| US20240270707A1 (en) * | 2021-04-15 | 2024-08-15 | Translate Bio, Inc. | "Good" buffer-based cationic lipids |
| CN120435314A (zh) | 2022-12-29 | 2025-08-05 | 波普瓦克斯私人有限公司 | 多靶疫苗和治疗剂 |
| WO2024171017A1 (en) * | 2023-02-13 | 2024-08-22 | Pfizer Inc. | Immunogenic composition against influenza |
| EP4701658A1 (en) * | 2023-04-27 | 2026-03-04 | GlaxoSmithKline Biologicals S.A. | Influenza virus vaccines |
| WO2024223724A1 (en) * | 2023-04-27 | 2024-10-31 | Glaxosmithkline Biologicals Sa | Influenza virus vaccines |
| CN121712487A (zh) * | 2023-06-28 | 2026-03-20 | 赛诺菲巴斯德有限公司 | 脂质纳米颗粒配制品中的固醇类似物 |
| WO2025092866A1 (zh) * | 2023-10-31 | 2025-05-08 | 仁景(苏州)生物科技有限公司 | 一种多价流感mRNA疫苗 |
| CN117205309B (zh) * | 2023-11-07 | 2024-02-02 | 今发制药(南京)有限公司 | 一种流感免疫原组合物和制备方法及其用途 |
| US20250332245A1 (en) * | 2023-11-15 | 2025-10-30 | Pfizer Inc. | Immunogenic compositions against influenza |
| CN117511969B (zh) * | 2024-01-04 | 2024-03-19 | 华南农业大学 | 一种mRNA、制备方法、用途和疫苗 |
| WO2025196065A1 (en) * | 2024-03-20 | 2025-09-25 | Sanofi | Novel homocysteine based lipids and their use for delivery of nucleic acids |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| EP1751289B1 (en) | 2004-05-18 | 2009-01-14 | Alphavax, Inc. | Tc-83-derived alphavirus vectors, particles and methods |
| US20110300205A1 (en) | 2009-07-06 | 2011-12-08 | Novartis Ag | Self replicating rna molecules and uses thereof |
| HUE042177T2 (hu) | 2009-12-01 | 2019-06-28 | Translate Bio Inc | Szteroidszármazék mRNS szállítására humán genetikai betegségekben |
| WO2012075040A2 (en) | 2010-11-30 | 2012-06-07 | Shire Human Genetic Therapies, Inc. | mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES |
| PL3586861T3 (pl) | 2011-06-08 | 2022-05-23 | Translate Bio, Inc. | Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna |
| KR102451116B1 (ko) | 2011-10-27 | 2022-10-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 약물 캡슐화 마이크로스피어를 형성할 수 있는, ｎ-말단 상에 관능화된 아미노산 유도체 |
| US10245229B2 (en) | 2012-06-08 | 2019-04-02 | Translate Bio, Inc. | Pulmonary delivery of mRNA to non-lung target cells |
| CN105051213A (zh) | 2013-03-14 | 2015-11-11 | 夏尔人类遗传性治疗公司 | 信使rna加帽效率的定量评估 |
| US10130649B2 (en) | 2013-03-15 | 2018-11-20 | Translate Bio, Inc. | Synergistic enhancement of the delivery of nucleic acids via blended formulations |
| SG11201510747RA (en) | 2013-08-21 | 2016-03-30 | Curevac Ag | Method for increasing expression of rna-encoded proteins |
| ES2806575T3 (es) | 2013-11-01 | 2021-02-18 | Curevac Ag | ARN modificado con propiedades inmunoestimuladoras disminuidas |
| KR102399799B1 (ko) | 2013-12-30 | 2022-05-18 | 큐어백 아게 | 인공 핵산 분자 |
| CA2927254C (en) | 2013-12-30 | 2023-10-24 | Curevac Ag | Artificial nucleic acid molecules |
| BR112016030852A2 (pt) | 2014-07-02 | 2018-01-16 | Shire Human Genetic Therapies | encapsulação de rna mensageiro |
| DE202015010000U1 (de) | 2014-12-12 | 2023-07-03 | CureVac SE | Artifizielle Nukleinsäuremoleküle für eine verbesserte Proteinexpression |
| ES2897823T3 (es) | 2015-04-30 | 2022-03-02 | Curevac Ag | Poli(N)polimerasa inmovilizada |
| ES2949540T3 (es) | 2015-06-19 | 2023-09-29 | Massachusetts Inst Technology | 2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula |
| WO2017070620A2 (en) * | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| WO2017162265A1 (en) | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Trans-replicating rna |
| BR112019008481A2 (pt) * | 2016-10-26 | 2020-03-03 | Curevac Ag | Vacinas de mrna de nanopartículas lipídicas |
| MX2019005470A (es) | 2016-11-10 | 2019-11-21 | Translate Bio Inc | Formulación de nanopartículas lipídicas basadas en ice mejorada para el suministro de arnm. |
| WO2018089801A1 (en) | 2016-11-10 | 2018-05-17 | Translate Bio, Inc. | Improved process of preparing mrna-loaded lipid nanoparticles |
| WO2018089851A2 (en) * | 2016-11-11 | 2018-05-17 | Modernatx, Inc. | Influenza vaccine |
| EP3849617A1 (en) * | 2018-09-14 | 2021-07-21 | Translate Bio, Inc. | Composition and methods for treatment of methylmalonic acidemia |
| US12579423B2 (en) | 2019-10-21 | 2026-03-17 | Sanofi Pasteur, Inc. | Systems and methods for predicting biological responses |
| WO2021080990A1 (en) | 2019-10-21 | 2021-04-29 | Sanofi Pasteur, Inc. | Systems and methods for designing vaccines |
-
2022
- 2022-06-17 KR KR1020247001675A patent/KR20240022610A/ko active Pending
- 2022-06-17 CA CA3224175A patent/CA3224175A1/en active Pending
- 2022-06-17 WO PCT/IB2022/055655 patent/WO2022264109A1/en not_active Ceased
- 2022-06-17 IL IL309408A patent/IL309408A/en unknown
- 2022-06-17 JP JP2023577590A patent/JP2024528418A/ja active Pending
- 2022-06-17 EP EP22734371.2A patent/EP4355308A1/en active Pending
- 2022-06-17 AU AU2022294274A patent/AU2022294274A1/en active Pending
- 2022-06-17 US US17/843,445 patent/US20230043128A1/en active Pending
- 2022-06-17 MX MX2023015464A patent/MX2023015464A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240091154A1 (en) | LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES | |
| JPWO2022264109A5 (https=) | ||
| JP6185548B2 (ja) | インフルエンザワクチンの製造方法 | |
| JP5450402B2 (ja) | インフルエンザを阻害する組成物および方法 | |
| KR20230104223A (ko) | mRNA 백신 전달을 위한 지질 나노입자 | |
| JP2024528418A (ja) | 多価インフルエンザワクチン | |
| JPWO2021239880A5 (https=) | ||
| WO2017223231A1 (en) | (s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza | |
| JPWO2022099003A5 (https=) | ||
| KR20240002207A (ko) | 코로나바이러스 백신 | |
| Yang et al. | Influenza virus entry inhibitors | |
| US12121503B2 (en) | Antiviral treatments | |
| CN121419787A (zh) | 多价流感mRNA疫苗 | |
| Hendy et al. | Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine | |
| CN104784166A (zh) | 抗病毒化合物、包含该化合物的剂型及其用途 | |
| AU2015323334B2 (en) | Vaccination of immunocompromised subjects | |
| RU2024101100A (ru) | Поливалентные вакцины против гриппа | |
| HK1212250A1 (en) | Antiviral compounds, unit dosage form comprising said compounds and use thereof | |
| JPWO2021202734A5 (https=) | ||
| RU2023114690A (ru) | ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНA | |
| CN117580568A (zh) | 多价流感疫苗 | |
| JPWO2022244825A5 (https=) | ||
| CN116367843A (zh) | 病毒抑制剂 | |
| AU2016262644B2 (en) | Intravenous antiviral treatments | |
| JPWO2023079113A5 (https=) |